Skip to main content

Advertisement

SpringerLink
Log in

The Gynecologist and Cardiovascular Disease: A Window of Opportunity for Prevention

  • Review Article
  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

We present current concepts and assess the quality of information available for the prevention of cardiovascular disease in women.

Methods

This article reviews research bearing on the prevention of cardiovascular disease in women, with particular attention to modifiable risk factors. We describe the magnitude of the problem and assess the quality of the data with respect to the classic risk factors. The concept is emphasized that changes at menopause, states of endocrine aberration, and benefits and risks of hormone substitution and oral contraception must be understood in conjunction with all other potentially modifiable and nonmodifiable risk factors.

Conclusions

Primary care phyiicians, especially obstetrician/gynecologists, have a pivotal drole to play in the reduction of this disease. Behavior modification is the key to integrating prevention into the regular annual visit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grimes DA. Prevention of cardiovascular disease in women: Role of the obstetrician-gynecologist. Am J Obstet Gynecol 1988;158:1661–8.

    Google Scholar 

  2. Heller RF, Jacobs HS. Coronary heart disease in relation to age, sex, and the menopause, Br Med J; 1978;1:472–4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Oklahoma City Department of Commerce, 1993.

  4. The Framingham Study, DHEW, NIH, No. 74, 8559, 1974.

    Google Scholar 

  5. Colditz GA, Wlllett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–10.

    Article  CAS  PubMed  Google Scholar 

  6. Ask-Upmark E. Life and death without ovaries. Acta Med Scand 1962;173:129.

    Google Scholar 

  7. Higano N, Robinson RW, Cohen WD. Increased incidence of cardiovascular disease in castrated women. N Engl J Med 1963;268:1123.

    Article  CAS  PubMed  Google Scholar 

  8. Novak ER, Williams TJ. Autopsy comparison of cardiovascular changes in castrated and normal women. Am J Obstet Gynecol 1960;80:863.

    Article  CAS  PubMed  Google Scholar 

  9. Randall CL, Paloncek FP, Graham JB, Graham S. Causes of death in esses of pre-climacteric menorrhagia. Am J Obstet Gynecol 1964;88:880.

    Article  CAS  PubMed  Google Scholar 

  10. Knopp RH, LaRosa JC, Burkman RT Jr. Contraception and dyslipidemia. Am J Obstet Gynecol 168;vn6:1994-2005.

  11. Kannel WB. Nutrition and the occurrence and prevention of cardiovascular disease in the elderly. Nutr Rev 1988;46: 68–78.

    Article  CAS  PubMed  Google Scholar 

  12. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641–6.

    Article  CAS  PubMed  Google Scholar 

  13. Meilahn EN, Kuller LH, Matthews KA, Wing RR, Hauth B. Change in lipoproteins and weight with menopause-impact of hormone therapy use after 5 years. The Healthy Women Study. Circulation Suppl 1993;88:Abstract E1186:I–222.

    Google Scholar 

  14. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1992;153:2209–16.

    Article  Google Scholar 

  15. Oster P, Arab L, Kohlmeier M, Mordasini R, Schellenberg B, Schliere G. Effects of estrogens and progestogens on lipid metabolism. Am J Obstet Gynecol 1982;142: 773–5.

    Article  CAS  PubMed  Google Scholar 

  16. Rifkind BM, Tamir I, Heiss G, Wallace RB, Tyroler HA. Distribution of high density and other lipoproteins in selected LRC prevalence study populations: A brief survey. Lipids 1979;14:105–12.

    Article  CAS  PubMed  Google Scholar 

  17. Wilson P, et al. Arteriosclerosis 1983;3:273.

    Article  CAS  PubMed  Google Scholar 

  18. Ramcharan S, Pellegrin FA, Ray RM, Hsu JP. The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. J Reprod Med 1980;25:345–72.

    CAS  PubMed  Google Scholar 

  19. Krauss RM, Perlman JA, Ray R, Petitti D. Relationship of estrogens and progestins to cardiovascular risk. in women. Am J Obstet Gynecol 1988;158(suppl):1606–11.

    Article  CAS  PubMed  Google Scholar 

  20. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977;62: 707–14.

    Article  CAS  PubMed  Google Scholar 

  21. Adams MR, Clarkson TB, Koritnik DR, Nash HA. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fertil Steril 1987;47:1010–8.

    Article  CAS  PubMed  Google Scholar 

  22. Adams MR, Clarkson TB, Shively CA, et al. Oral contraceptives, lipoproteins and atherosclerosis. Am J Obstet Gynecol 1990;163:1388–93.

    Article  CAS  PubMed  Google Scholar 

  23. Lammers P, Atsma WJ. Mettabolic effects of low-dose oral contraceptive containing 20 mcg ethinyloestradiol. Organorama 1990;27:3–5.

    Google Scholar 

  24. Lobo RA. Cardiovascular implications of estrogen replacement therapy. Am J Obstet Gynecol 1990;75::8S–25S; 31S-5S.

    Google Scholar 

  25. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452–9.

    Article  CAS  PubMed  Google Scholar 

  26. Reis SE, Gloth ST, Blumenthal S, Zacur H, Gerstenslith G, Brinker JA. Acute effects of intravenous estrogen on coronary artery vasoactivity in postmenopausal women. Circulation 1992;86:Abstract #3448.

  27. Knopp RH. Cardiovascular effects of endogenous and exogenous sex hormones over a woman’s lifetime. Am J Obstet Gynecol 1988;158:1630–43.

    Article  CAS  PubMed  Google Scholar 

  28. Harrison DG, Freiman PC, Mitchel GG, Armstrong ML, Marcus ML, Heistad DD. Alterations of vascular reactivity in atherosclerosis. Circ Res 1987;61(suppl II)::II7-II-80.

    Google Scholar 

  29. Wren BG. The effect of oestrogen on the female cardiovascular system. Med J Aust 1992;157:204–8.

    Article  CAS  PubMed  Google Scholar 

  30. Fischer-Dzoga K, Wissler RW, Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol 1983;39:355–63.

    Article  CAS  PubMed  Google Scholar 

  31. Rhee CY, Spaet TH, Gaynor E, et al. Suppression of surgically induced vascular intimal hypertrophy by estrogen (abstract). Circulation 1974;49(suppl III):iii–9.

    Google Scholar 

  32. Rhee CY, Drouet RO, Spaet YH, Geiger CH. Growth inhibition of cultured vascular smooth muscle cells by estradiol. Fed Proc 1978;37:474.

    Google Scholar 

  33. Weigensberg BI, Lough H, More RH, Katz E, Pugash E, Peniston C. Effects of estradiol on myointimal thickening from catheter injury and on orginizing white mural non-occlusive thrombi. Atherosclerosis 1984;52:253–65.

    Article  CAS  PubMed  Google Scholar 

  34. Hough JL, Zilversmit DB. Effect of 17β-estradiol on aortic cholesterol content and metabolism in cholesterolfed rabbits. Atherosclerosis 1986;61.57–63.

    Article  Google Scholar 

  35. Chang WC, Nakao J, Orimo H, Murota SI. Stimulation of prostacyclin activity by estradiol in rat aorta smooth muscle cell in culture. Biochem Biophys Acta 1980;619: 107–18.

    Article  CAS  PubMed  Google Scholar 

  36. Miller VM, Gisclard V, Vanhoutte PM. Modulation of endothelium-dependent and vascular smooth muscle responses by oestrogens. Phlebology 1988;224:19–22.

    Google Scholar 

  37. Burch JC, Byrd BF, Vaughn WK. The effects of long-term estrogen support after hysterectomy. Ann Surg 1977; 185:574–80.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Pick R, Stamler J, Rodbard S, et al. The inhibition of coronary atherosclerosis by estrogens in cholesterolfed chicks. Circulation 1952;6:276–80.

    Article  CAS  PubMed  Google Scholar 

  39. Pick R, Stamler J, Rodbard S, et al. Estrogen-induced regression of coronary atherosclerosis in cholesterol-fed chicks. Circulation 1952;6:858–61.

    Article  CAS  PubMed  Google Scholar 

  40. Ludden JB, Bruger M, Wright IS. Experimental athero-sclerosis; eltect of testosterone propionate and oestradiol dipropionate on experimental atherosclerosis in rabbits. Arch Pathol 1942;33:58–62.

    CAS  Google Scholar 

  41. Rosano GMC. Benfficial effect of oestrogen in exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993;342:133–6.

    Article  CAS  PubMed  Google Scholar 

  42. Shwaery GT, Sacchiero RJ, Judd SG, Nicolosi RJ, Foxall TL. Effects of estrogen on oxidation ex vivo of low density lipoprotein from hypercholesterolemic swine. Circulation Suppl 1993;88:4 Abstract #3029:I-563.

    Article  Google Scholar 

  43. Sayegh HS, Ohara Y, Navss JP, Peterson TE, Dockery S, Harrison DG. Endothelial nitric oxide synthase regulation by estrogens. Circulation Suppl 1993;88:4 Abstract #0415:1—80.

    Article  Google Scholar 

  44. Lamping KG, Nuno DW. Estradiol and progesterone attenuate contractions to endothelin in coronary microvessels in vitro. Circulation Suppl 1993;88:4 Abstract #2535:I-471.

    Article  Google Scholar 

  45. Collins P, Jiang C, Shay J, Moss J. In vitro EDRF-dependent coronary artery relaxation to physiologic concentrations of 17P-estradiol: Modulation by in vitro sex hormone status. Circulation Suppl 1993;88:4 Abstract #0410:1–79.

    Article  Google Scholar 

  46. Schray-Utz B, Zelher AM, Busse R. Expression of constitutive no synthase in cultured endothelial cells is enhanced by 17P-estradiol. Circulation Suppl 1993;88:4 Ab-stract #0416:1–80.

    Article  Google Scholar 

  47. Akishita M, Ouchi Y, Kim S, Toba K, Orimo H. Regulation of endothelin-1 production by estrogen. Circulation Suppl 1993;88:4 Abstract #1778:I-332.

    Article  Google Scholar 

  48. Keany JF Jr, Shwaery GT, Xu A, Nicolosi RJ, Foxall TL, Vita JA. Preservation of endothllial function in hypercholesterolemia through the antioxidant properties of estrogens. Circulation Suppl 1993;88:4 Abstract #0411:I-79.

    Article  Google Scholar 

  49. Chester A, Jiang C, Sarrel P, Borland J, Yacoub M, Collins P. 17p-Estradiol induces endothelium-independent relaxation in human coronary arteries in vitro. Circulation Suppl 1993;88:4 Abstract #0407:I-78.

    Article  Google Scholar 

  50. Zhu XD, Knopp RH. Effect of sex hormones on oxidative moiification of low density lipoproteins by placental rophages and trophoblast and their susceptibility to cytotoxicity. Circulation Suppl 1993;88:4 Abstract #0160:I-32.

    Article  Google Scholar 

  51. Volteranni M, Romano G, Collins P. Effect of estradiol-17p upon forearm blood flow in menopausal women. A double blind randomized study. Circulation Suppl 1993; 88:4 Abstract #2016:I-376.

  52. Reis SE, Blumenthal RS, Gloth ST, Resar JR, Gersten-blith G, Brinker JA. Estrogen abolishes abnormal coronary response to acetylcholine in postmenopausal women. Circulation Suppl 1993;88:4 Abstract #1390:I-259.

    Article  Google Scholar 

  53. Lieberman EH, Gerhard M, Yeung AC, et al. Estrogen improves coronary vasomotor responses to acetylcholine in post menopausal women. Circulation Suppl 1993;88:4 Abstract #0412:1—79.

    Article  Google Scholar 

  54. Lieberman EH, Gerhard M, Uehata A, et al. Estrogen improves flow-mediated dilation of the brachial artery in post menopausal women. Circulation Suppl 1993;88:4 Abstract #1391:I-259.

    Article  Google Scholar 

  55. Collins P, Rosano G, Adamopoulos S, et al. Reversal of acetylcholine-induced vasoconstriction by intracoronary administration of estradiol-17p in menopausal women with coronary artery disease. Circulation Suppl 1993;88:4 Abstract #3168:I-589.

    Article  Google Scholar 

  56. Gilligan DM, Quyyumi AA, Johnson BG, Cannon RO. Estradiol acutely potentiates coronary endothelium-dependent vasodilation in postmenopausal women. Circulation Suppl 1993;88:4 Abstract #0414:I-79.

    Article  Google Scholar 

  57. Gilligan DM, Badar DA, Panza JA, Quyyumi AA, Cannon RO. The effects of estrogen on endothelium-dependent vasodilation in postmenopausal women. Circulation Suppl 1993;88:4 Abstract #0413:I-79.

    Article  Google Scholar 

  58. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47–63.

    Article  CAS  PubMed  Google Scholar 

  59. Stampfer MJ, Colditz GA, Wlllett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses’ Health Study. N Engl J Med 1991;325:756–62.

    Article  CAS  PubMed  Google Scholar 

  60. Wilson PWF, Garrison RJ, Cattelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity m women over DO: The Framingham Study. JN Engl J Med 1985;313:1038–43.

    Article  CAS  Google Scholar 

  61. International Consensus Conference on Postmenopausal Hormone Therapy and the Cardiovascular System. American Fertility Society, Amrrican Heart Association. Fertil Steril 1994;61:592–5.

    Article  Google Scholar 

  62. Sempos C, Fulwood R, Haines C. The prevalence of high blood cholesterol levels among adults in the United States. JAMA 1989;262:45–52.

    Article  CAS  PubMed  Google Scholar 

  63. Expert panel report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adllts. Arch Intern Med 1988;148:36–69.

    Article  Google Scholar 

  64. NHLBI. Declining serum cholesterol levels among U.S. adults. JAMA 1993;269:23.

    Google Scholar 

  65. LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts: A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease: A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Circulation 1990; 81:1721–33.

    Article  CAS  PubMed  Google Scholar 

  66. National Research Council, Committee on Diet and Health. Diet and health: Implications for reducing chronic disease risk. Washington, DC: National Academy Press, 1989.

    Google Scholar 

  67. Wilson PWF, Christiansen JC, Anderson KM, Kannel WB. Impact of national guidelines for cholesterol risk factor screening: The Framingham Offspring Study. JAMA 1989;262:41–4.

    Article  CAS  PubMed  Google Scholar 

  68. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988;260:2259–63.

    Article  CAS  PubMed  Google Scholar 

  69. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adllts. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on the detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015–23.

    Article  Google Scholar 

  70. Williams GH, Jagger PI, Braunwald E. Hypertensive vascular disease. In: Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD, eds. Harrison’s principles of internal medicine. 9th ed. Vol. 2. New York: McGraw-Hill, 1980:1167–78.

    Google Scholar 

  71. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease: Part 2. Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiologic context. Lancet 1990;335:827–38.

    Article  CAS  PubMed  Google Scholar 

  72. Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med 1992; 326:1406–16.

    Article  CAS  PubMed  Google Scholar 

  73. Hebert PR, Fiebach NH, Eberlein KA, Taylor JO, Hennekens CH. The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension. Am J Epidemiol 1988;127:581–90.

    Article  CAS  PubMed  Google Scholar 

  74. Hennekens CH, Satterfield S, Hebert PR. Treatment of elevated blood pressure to prevent coronary heart disease. In: Higgins MW, Luepker RV, eds. Trends in coronary heart disease mortality: The influence of medical care. New York: Oxford University Press, 1988:103–8.

    Google Scholar 

  75. 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023–38.

    Article  Google Scholar 

  76. Department of Health and Human Services. Reducing the health consequences 01 smoking: zo years of progress: A report of the Surgeon Genrral. DHHS publication no. CDC 89–8411. Washington, DC: Government Printing Office, 1989.

    Google Scholar 

  77. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987;317: 1303–9.

    Article  CAS  PubMed  Google Scholar 

  78. Doll R, Peto R. Mortality in relation to smoking: 20 years’ observation on male British doctors. Br Med J 1976;2: 1525–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myoaardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313: 1511–4.

    Article  CAS  PubMed  Google Scholar 

  80. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990;322:213–7.

    Article  CAS  PubMed  Google Scholar 

  81. LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991;324:1619–25.

    Article  CAS  PubMed  Google Scholar 

  82. Doyle JT, Dawber TR, Kannel WB, Kinch SH, Kahn HA. The relationship of cigarette smoking to coronary heart disease: The second report of the combined experience of the Albany, NY, and Framingham, Mass, studies. JAMA 1946;190:886–90.

    Google Scholar 

  83. Hammond EC, Garfinkel L. Coronary heart disease, stroke, and aortic aneurysm: Factors in the etiology. Arch Environ Health 1969;19:167–82.

    Article  PubMed  Google Scholar 

  84. Department of Health and Human Services. The health benefits of smoking cessation: A report of the Surgeon Genrral. DHHS publication no. (CDC)90–8416. Washington, DC: Government Printing Office, 1990.

    Google Scholar 

  85. Gordon T, Kannel WB, McGee D, Dawber TR. Death and coronary attacks in men after giving up cigarette smoking: A report from the Framingham Study. Lancet 1974;ii:1345–8.

    Article  Google Scholar 

  86. Rogot E, Murray JL. Smoking and causes of death among U.S. veterans: 16 years of observations. Public Health Rep 1980;95:213–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Hennekens CH, Evans D, Peto R. Oral contraceptive use, cigarette smoking and myoaardial infarction. Br J Fam Plann 1979;5:66–7.

    Google Scholar 

  88. Shapiro S, Slone D, Rosenberg L, Kaufman DW. Oral-contraceptive use in relation to myoaardial infarction. Lancet 1979;i:743–6.

    Article  Google Scholar 

  89. Suarez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mlllitus in the prediction of death attributed to cardiovascular disease. Am J Eiidemiol 1984; 120:670–5.

    Article  CAS  Google Scholar 

  90. National Institutes of Health Consensus Development Panel on the Health Implications of Obesity. Health implications of obesity: National Institutes of Health Con-sensus Development Conference statement. Ann Intern Med 1985;103:1073–7.

    Article  Google Scholar 

  91. Simopoulos AP, Van Italie TB. Body weight, health, and longevity. Ann Intern Med 1984;100:285–95.

    Article  CAS  PubMed  Google Scholar 

  92. Lew EA, Garfinkel L. Variations in mottality by weight among 750,000 men and women. J Chronic Dis 1979;32: 563–76.

    Article  CAS  PubMed  Google Scholar 

  93. Hubert HB, Feinleib M, McNamara PM, Cattelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968–77.

    Article  CAS  PubMed  Google Scholar 

  94. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1981;54:254–60.

    Article  Google Scholar 

  95. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women: Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Bjorntorp P. Regional patterns of fat distribution. Ann Intern Med 1985;103:994–5.

    Article  CAS  PubMed  Google Scholar 

  97. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl Med 1990;322:882–9.

    Article  CAS  Google Scholar 

  98. National Center for Health Statistics. Provisional data from the Health Promotion and Disease Prevention Supplement to the National Health Interview Survey: United States January-March 1985. Advance data from vital and health statistics. DHHS publication no. PHS 86–1250. No. 113, Hytttsville, Maryland: Public Health Service, 1985:2–5.

    Google Scholar 

  99. Committee on Diet and Health. Diet and health: Implications for reducing chronic disease risk. Washington, DC: National Academy Press, 1989.

    Google Scholar 

  100. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Ann Rev Public Health 1987;8:253–87.

    Article  CAS  Google Scholar 

  101. Slattery ML, Jacobs DR Jr, Nichaman MZ. Leisure time physical activity and coronary heart disease death: The US Railroad Study. Circulation 1989;79:304–11.

    Article  CAS  PubMed  Google Scholar 

  102. Leon AS, Connet J, Jacobs DR, Raumaraa R. Leisure-time physical activity levels and risk of coronary heart disease and death: The Mlltiple Risk Factor Intervention Trial. JAMA 1987;258:2388–95.

    Article  CAS  PubMed  Google Scholar 

  103. Kannel WB, Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med 1979; 139:857–61.

    Article  CAS  PubMed  Google Scholar 

  104. Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh CC. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986;314:605–13.

    Article  PubMed  Google Scholar 

  105. Brunner D, Manelis G, Modan M, Levin S. Physical activity at work and the incidence of myoaardial infarction, angina pectoris and death due to ischemic heart disease: An epidemiological study in Israeli collective settlements (Kibbutzim). J Chronic Dis 1974;27:217–33.

    Article  CAS  PubMed  Google Scholar 

  106. Cooksey JD, Reilly P, Brown S, Bomze H, Cryer PE. Exercise training and plasma catecholamines in patients with ischemic heart disease. Am J Cardiol 1978;42:372–6.

    Article  CAS  PubMed  Google Scholar 

  107. Oberman A. Rehabilitation of patients with coronary artery disease. In: Braunwald E, ed. Heart disease: A textbook of cardiovascular medicine. 3rd ed. Philadelphia: WB Saunders, 1988:1395–409.

    Google Scholar 

  108. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990;132:612–28.

    Article  CAS  PubMed  Google Scholar 

  109. United States Preventive Services Task Force. Guide to clinical preventive services: An assessment of the effectiveness of 169 interventions. Baltimore: Williams & Wilkins, 1989:375–9.

    Google Scholar 

  110. West KM. Epidemiology of diabetes and its vascular lesions. New York: Elsevier, 1978.

    Google Scholar 

  111. Butler WJ, Ostrander LD Jr, Carman WJ, Lamphiear DE. Mortality from coronary heart disease in the Tecumseh study: Long-term effect of diabetes mlllitus, glucose tolerance and other risk factors. Am J Epidemiol 1985;121: 541–7.

    Article  CAS  PubMed  Google Scholar 

  112. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 1979;2:120–6.

    Article  CAS  PubMed  Google Scholar 

  113. Heyden S, Heiss G, Bartel AG, Hames CG. Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chronic Dis 1980;33:26–73.

    Google Scholar 

  114. Barrett-Connor E, Wingard DL. Sex differential m ischemic heart disease mottality in diabetics: A prospective population-based study. Am J Epidemiol 1983;118:489–96.

    Article  CAS  PubMed  Google Scholar 

  115. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term comllications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.

    Article  Google Scholar 

  116. Henderson JJE, Pagamm-Hill A, Ross RK. Decreased mottality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75–8.

    Article  CAS  PubMed  Google Scholar 

  117. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy I: A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979;53:277–83.

    CAS  PubMed  Google Scholar 

  118. Hammond CB, Maxson WS. Current status of estrogen therapy for the menopause. Fertil Stenl 1982;37:5–12.

    Article  CAS  Google Scholar 

  119. Henderson BE, Ross RK, Pagamni-Hili A. Estrogen use and cardiovascular disease. J Reprod Med 1985;30(suppl): 814–120.

    CAS  PubMed  Google Scholar 

  120. Soma MR, Osagno-Gadda I, Pacletti R, et al. The lowering of lipoprotein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 1993;153:1462–8.

    Article  CAS  PubMed  Google Scholar 

  121. National Center for Health Statistics. Provisional data from the Health Promotion and Disease Prevention Supplement to the National Health Interview Survey: United States, January-March 1985. Advance data from vital and health statistics. DHHS publication no. PHS 86–1250. No. 113. Hytttsville, Maryland: Public Health Service, 1985:2–5.

    Google Scholar 

  122. MacLennan A. Women, cardiovascular disease and hormone replacement teerapy. Med J Aust 1992;156:77–78.

    Article  CAS  PubMed  Google Scholar 

  123. Loriaux DL, Wild RA. Contraceptive choices for women with endocrine complications. Am J Obstet Gynecol 1993;168(suppl):2021–6.

    Google Scholar 

  124. Wild RA, Taylor EL, Knehans AW, Cleaver VL. The matriarchal model for the prevention of cardiovascular risk. Obstet Gynecol Surv 1994;49:147–52.

    Article  CAS  PubMed  Google Scholar 

  125. ACOG practice guidelines. Washington, DC: The American College of Obttetricians and Gynecologists} (in press, 1994).

  126. Stange KC, Kelly R, Chao J, et al. Physician agreement with US Preventive Services Task Force recommendations. J Fam Pract 1992;34:409–16.

    CAS  PubMed  Google Scholar 

  127. Pommerenke FA, Dietrich A. Improving and maintaining preventive service. Part 1: Applying the patient model. J fam Pract 1992;34:86–91

    CAS  PubMed  Google Scholar 

  128. Pommerenke FA, Dietrich A. Improving and maintaining preventive services. Part 2: Practical principles for primary care. J Fam Pract 1992;34:92–7.

    CAS  PubMed  Google Scholar 

  129. Gold MR. Healthy people 2000: Access to preventive services for all. J Fam Pract 1992;34:401–3.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Obttetrics and Gynecology and Medicine (Cardiology), University of Oklahoma Health Sciences Center, Oklahoma City, P.O. Box 26901, 4SP720, Oklahoma City, OK, 73190, USA

    Robert A. Wild MD, E. Laurette Taylor PhD & Allen Knehans PhD

  2. Department of Health & Sport Sciences, College of Arts and Sciences, University of Oklahoma, Norman, USA

    Robert A. Wild MD & E. Laurette Taylor PhD

  3. Department of Clinical Dietetics, College of Allied Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

    Robert A. Wild MD & E. Laurette Taylor PhD

Authors
  1. Robert A. Wild MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Laurette Taylor PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allen Knehans PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported m part by The Preventive Cardiology Academic Award, [National Heart, Lung and Blood Institute, no. 1 K07 HL02669-01

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wild, R.A., Taylor, E.L. & Knehans, A. The Gynecologist and Cardiovascular Disease: A Window of Opportunity for Prevention. Reprod. Sci. 1, 107–117 (1994). https://doi.org/10.1177/107155769400100203

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/107155769400100203

Key words

Search

Navigation